Skip to content
Recall Observatory FDA recall evidence

Device product

INOmax DSIR, model 10007, Nitric Oxide Delivery System, with Software version 3.0.0. The INOmax DS delivery system delivers INOMAX (nitric oxide for inhalation) therapy gas and provides continuous monitoring of inspired O2, NO2, and NO, and a comprehensive alarm system. The primary targeted clinical setting is the Neonatal Intensive Care Unit (NICU) and secondary targeted clinical setting is the transport of neonates.

Z-1528-2014

March 27, 2014

Class II

Product summary

Firm
INO Therapeutics (dba Ikaria)
Event
Event 67947
Status
Terminated
Classification
Class II
Quantity
22
Official record key
device-enforcement:Z-1528-2014

Official wording

Reason: An anomaly impacts the monitoring system of INOmax DSIR Plus (software 3.0.0). When the integrated pneumatic backup switch is activated with low or no gas flow through the injector module, an intended NO cell failure alarm will occur. In addition, an unintended NO2 cell failure alarm may also occur. The NO/NO2 cell failure alarms are caused by an average NO/NO2 circuit concentration greater tha

Code information: Serial Numbers: DS20080152, DS20090218, DS20090243, DS20090271, DS20090523, DS20090598, DS20090821, DS20090925, DS20101022, DS20101076, DS20101147, DS20101374, DS20101413, DS20101420, DS20101499, DS20101637, DS20111199, DS20120099, DS20120150, DS20120169, DS20120288, DS20120306.

Distribution pattern: Nationwide Distribution including DC and VA.

Derived failure modes

  • Device software or design

    reason.device_software_design · v1.0.0

    anomaly impacts the monitoring system of INOmax DSIR Plus (software